Title | Type | SJR | H index | Total Docs. (2011) | Total Docs. (3years) | Total Refs. (2011) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2011) | %Female (2011) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Nature Reviews Drug Discovery | journal | 6.281 Q1 | 391 | 225 | 603 | 6565 | 6481 | 465 | 9.54 | 29.18 | 24.42 | |
2 | Natural Product Reports | journal | 3.285 Q1 | 211 | 82 | 218 | 15034 | 1973 | 209 | 9.13 | 183.34 | 28.24 | |
3 | Drug Discovery Today | journal | 1.928 Q1 | 215 | 139 | 444 | 8041 | 3049 | 410 | 6.59 | 57.85 | 27.25 | |
4 | Current Opinion in Drug Discovery and Development | journal | 1.565 Q1 | 85 | 0 | 215 | 0 | 1005 | 203 | 4.75 | 0.00 | 0.00 | |
5 | Expert Opinion on Biological Therapy | journal | 1.312 Q1 | 102 | 141 | 459 | 11869 | 1848 | 452 | 4.34 | 84.18 | 33.72 | |
6 | Expert Opinion on Therapeutic Targets | journal | 1.575 Q1 | 106 | 112 | 352 | 10954 | 1340 | 348 | 4.13 | 97.80 | 38.98 | |
7 | BMC Chemical Biology | journal | 1.979 Q1 | 21 | 2 | 17 | 74 | 73 | 17 | 4.07 | 37.00 | 30.77 | |
8 | Expert Review of Vaccines | journal | 1.405 Q1 | 105 | 167 | 435 | 11738 | 1689 | 350 | 3.91 | 70.29 | 30.99 | |
9 | Current Opinion in Molecular Therapeutics | journal | 1.475 Q1 | 67 | 0 | 236 | 0 | 885 | 224 | 3.86 | 0.00 | 0.00 | |
10 | Expert Opinion on Therapeutic Patents | journal | 1.129 Q1 | 88 | 112 | 329 | 9333 | 991 | 320 | 3.86 | 83.33 | 29.36 | |
11 | Current Opinion in Investigational Drugs | journal | 1.423 Q1 | 83 | 0 | 406 | 0 | 1554 | 382 | 3.82 | 0.00 | 0.00 | |
12 | Tetrahedron | journal | 1.473 Q1 | 236 | 1196 | 3799 | 59894 | 13155 | 3772 | 3.40 | 50.08 | 29.21 | |
13 | ChemMedChem | journal | 1.267 | 119 | 235 | 640 | 9505 | 2264 | 626 | 3.29 | 40.45 | 37.40 | |
14 | Bioorganic and Medicinal Chemistry | journal | 1.137 Q1 | 187 | 787 | 2774 | 30152 | 9178 | 2766 | 3.21 | 38.31 | 34.25 | |
15 | Human Genomics | journal | 1.126 Q1 | 68 | 36 | 89 | 1912 | 262 | 75 | 3.08 | 53.11 | 41.72 | |
16 | Tetrahedron Letters | journal | 1.217 Q1 | 181 | 1736 | 5369 | 60571 | 16024 | 5368 | 3.01 | 34.89 | 26.96 | |
17 | Bioorganic and Medicinal Chemistry Letters | journal | 1.122 Q1 | 166 | 1516 | 4384 | 40378 | 12616 | 4382 | 2.81 | 26.63 | 32.82 | |
18 | Phytochemical Analysis | journal | 0.931 Q2 | 83 | 75 | 219 | 1857 | 593 | 214 | 2.79 | 24.76 | 37.80 | |
19 | RSC Medicinal Chemistry | journal | 74 | 171 | 48 | 6313 | 129 | 45 | 2.69 | 36.92 | 31.84 | ||
20 | Antiviral Chemistry and Chemotherapy | journal | 0.811 Q2 | 59 | 17 | 57 | 690 | 152 | 54 | 2.45 | 40.59 | 29.41 | |
21 | Chemical Biology and Drug Design | journal | 0.824 | 91 | 167 | 399 | 5951 | 1019 | 388 | 2.44 | 35.63 | 38.07 | |
22 | Biomarkers in Medicine | journal | 0.588 Q2 | 56 | 86 | 215 | 5033 | 442 | 176 | 2.32 | 58.52 | 34.26 | |
23 | Expert Opinion on Drug Discovery | journal | 0.621 Q2 | 84 | 92 | 288 | 8715 | 571 | 283 | 2.24 | 94.73 | 28.16 | |
24 | SAR and QSAR in Environmental Research | journal | 0.533 Q2 | 54 | 40 | 129 | 1795 | 269 | 128 | 2.04 | 44.88 | 41.94 | |
25 | Biomedical Chromatography | journal | 0.735 Q2 | 71 | 164 | 550 | 5271 | 1101 | 539 | 2.01 | 32.14 | 35.45 | |
26 | Future Medicinal Chemistry | journal | 0.845 Q2 | 90 | 166 | 260 | 10362 | 506 | 196 | 1.95 | 62.42 | 26.29 | |
27 | Journal of Peptide Science | journal | 0.783 Q2 | 73 | 113 | 369 | 3995 | 706 | 360 | 1.78 | 35.35 | 40.23 | |
28 | Journal of Antibiotics | journal | 0.648 Q2 | 92 | 132 | 353 | 3602 | 594 | 344 | 1.66 | 27.29 | 28.74 | |
29 | Journal of Enzyme Inhibition and Medicinal Chemistry | journal | 0.487 Q3 | 92 | 110 | 431 | 4132 | 731 | 429 | 1.63 | 37.56 | 29.21 | |
30 | International Journal of Cosmetic Science | journal | 0.474 Q3 | 77 | 77 | 133 | 2762 | 233 | 128 | 1.40 | 35.87 | 51.79 | |
31 | Protein and Cell | journal | 0.632 Q2 | 94 | 119 | 134 | 5192 | 179 | 126 | 1.34 | 43.63 | 36.75 | |
32 | Drug Discovery Today: Disease Mechanisms | journal | 0.504 Q2 | 28 | 15 | 78 | 807 | 107 | 70 | 1.15 | 53.80 | 30.77 | |
33 | Drug Discovery Today: Technologies | journal | 0.414 Q3 | 62 | 18 | 64 | 601 | 89 | 56 | 1.15 | 33.39 | 21.74 | |
34 | Pharmaceutical Biology | journal | 0.364 Q3 | 88 | 178 | 537 | 6266 | 648 | 531 | 1.10 | 35.20 | 39.60 | |
35 | Journal of Asian Natural Products Research | journal | 0.396 Q3 | 51 | 170 | 533 | 2915 | 563 | 532 | 1.09 | 17.15 | 36.90 | |
36 | DARU, Journal of Pharmaceutical Sciences | journal | 0.293 Q3 | 58 | 57 | 159 | 1338 | 167 | 158 | 0.86 | 23.47 | 28.04 | |
37 | EPMA Journal | journal | 0.152 Q4 | 52 | 50 | 57 | 2820 | 48 | 52 | 0.84 | 56.40 | 36.79 | |
38 | IDrugs : the investigational drugs journal | journal | 0.298 Q3 | 39 | 0 | 502 | 0 | 362 | 502 | 0.82 | 0.00 | 0.00 | |
39 | Journal of Labelled Compounds and Radiopharmaceuticals | journal | 0.325 Q3 | 54 | 119 | 339 | 3002 | 271 | 336 | 0.78 | 25.23 | 23.46 | |
40 | Drug Discovery Today: Therapeutic Strategies | journal | 0.375 Q3 | 31 | 23 | 71 | 651 | 63 | 60 | 0.68 | 28.30 | 31.65 | |
41 | Drug Discovery Today: Disease Models | journal | 0.364 Q3 | 33 | 24 | 79 | 1114 | 74 | 68 | 0.63 | 46.42 | 35.94 | |
42 | HIV Therapy | journal | 0.444 Q3 | 14 | 0 | 108 | 0 | 68 | 79 | 0.63 | 0.00 | 0.00 | |
43 | International Journal of Computational Biology and Drug Design | journal | 0.214 Q4 | 16 | 27 | 80 | 588 | 35 | 78 | 0.48 | 21.78 | 31.68 | |
44 | Drug Discovery World | journal | 0.172 Q4 | 14 | 38 | 136 | 609 | 34 | 122 | 0.22 | 16.03 | 20.00 | |
45 | RSC Drug Discovery Series | book series | 0.130 Q4 | 13 | 0 | 28 | 0 | 2 | 11 | 0.07 | 0.00 | 0.00 | |
46 | Sp2 | trade journal | 0.101 Q4 | 2 | 51 | 138 | 28 | 1 | 124 | 0.01 | 0.55 | 15.15 | |
47 | Future HIV Therapy | journal | 0.134 Q4 | 8 | 0 | 57 | 0 | 32 | 46 | 0.00 | 0.00 | 0.00 | |
48 | Journal of Biologically Active Products from Nature | journal | 18 | 37 | 0 | 1204 | 0 | 0 | 0.00 | 32.54 | 44.21 | ||
49 | MedChemComm | journal | 0.962 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
50 | Next Generation Pharmaceutical | trade journal | 0.100 Q4 | 1 | 31 | 190 | 0 | 0 | 132 | 0.00 | 0.00 | 0.00 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®